About Us

Mei Yeh

Mei Yeh


  • Postdoctoral Research Fellow, APCRC-Q
  • Member, IHBI, QUT

Contact Details

+61 7 3443 7266


PhD, University of Adelaide, South Australia, 2010

BSc Hons (First Class), University of Adelaide, South Australia, 2005

BSc, University of Adelaide, South Australia, 2004


Dr. Yeh obtained her Honours degree in immunology in 2005 from the University of Adelaide, where she investigated the role of c-jun NH2 terminal kinase in regulating the killing of S. aureus in neutrophil.  She undertook her PhD in Prof Antonio Ferrante’s lab investigating the immunomodulatory properties of quinolone-based fatty acids.  After completing her PhD degree, she took a three-year postdoctoral research position at the Lowy Cancer Research Centre, University of New South Wales in Sydney studying the anti-inflammatory properties of novel small molecule inhibitors in collagen-antibody-induced arthritis and atherosclerosis.  In 2014, she joined the APCRC-Q working on projects involved in developing novel prostate cancer target for diagnosis, imaging and detecting of response to therapy. 

Research interests

Prostate cancer, cancer imaging, nanobiotechnology

Top publications

1. Yeh, MC, Mukaro, V., Hii, C.S. & Ferrante, A. (2010) Regulation of neutrophil-mediated killing of Staphylococcus aureus and chemotaxis by c-jun NH2 terminal kinase. J Leuko Biol. May:87(5):925-32.

2. Fuchs AV*, Tse BW-C*, Pearce AK, Yeh MC, Fletcher N, Huang SS, Heston WD, Whittaker AK, Russell PJ, Thurecht K. Evaluation of polymeric nanomedicines targeted to PSMA: Effect of ligand on targeting efficiency.Biomacromolecules. 2015 (accepted for publication).